Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulodesine Added to Allopurinol in Gout with Renal Insufficiency
NCT01407874Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Sep 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ulodesine in gout, hyperuricemia, sponsored by BioCryst Pharmaceuticals, Inc.. Started Sep 2011; status: completed.
02
Drugs
Ulodesine
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT01407874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407874.